Susquehanna International Group’s VanEck Biotech ETF BBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$485K Buy
2,579
+1,391
+117% +$268K ﹤0.01% 9756
2025
Q4
$225K Sell
1,188
-8,166
-87% -$1.51M ﹤0.01% 10616
2025
Q3
$1.55M Buy
9,354
+4,411
+89% +$719K ﹤0.01% 6340
2025
Q2
$758K Sell
4,943
-713
-13% -$106K ﹤0.01% 8155
2025
Q1
$890K Buy
5,656
+155
+3% +$25.2K ﹤0.01% 7536
2024
Q4
$863K Buy
5,501
+3,628
+194% +$610K ﹤0.01% 7328
2024
Q3
$332K Sell
1,873
-8,744
-82% -$1.55M ﹤0.01% 9373
2024
Q2
$1.79M Buy
+10,617
New +$1.74M ﹤0.01% 5316
2024
Q1
Sell
-18,942
Closed -$3.13M 12159
2023
Q4
$3.13M Sell
18,942
-1,156
-6% -$178K ﹤0.01% 4486
2023
Q3
$3.13M Buy
20,098
+13,595
+209% +$2.17M ﹤0.01% 4303
2023
Q2
$1.01M Sell
6,503
-11,117
-63% -$1.78M ﹤0.01% 6642
2023
Q1
$2.86M Buy
17,620
+4,610
+35% +$746K ﹤0.01% 4429
2022
Q4
$2.08M Sell
13,010
-4,146
-24% -$657K ﹤0.01% 4626
2022
Q3
$2.42M Buy
17,156
+12,570
+274% +$1.9M ﹤0.01% 4549
2022
Q2
$669K Sell
4,586
-18,039
-80% -$2.69M ﹤0.01% 7543
2022
Q1
$3.67M Buy
22,625
+15,235
+206% +$2.47M ﹤0.01% 4246
2021
Q4
$1.4M Sell
7,390
-4,680
-39% -$902K ﹤0.01% 6392
2021
Q3
$2.44M Sell
12,070
-12,306
-50% -$2.58M ﹤0.01% 5408
2021
Q2
$4.92M Buy
24,376
+9,633
+65% +$1.79M ﹤0.01% 4065
2021
Q1
$2.59M Sell
14,743
-7,438
-34% -$1.34M ﹤0.01% 5304
2020
Q4
$3.76M Buy
22,181
+12,362
+126% +$2.04M ﹤0.01% 3925
2020
Q3
$1.59M Sell
9,819
-9,691
-50% -$1.58M ﹤0.01% 5054
2020
Q2
$3.18M Buy
19,510
+14,808
+315% +$2.25M ﹤0.01% 3706
2020
Q1
$602K Sell
4,702
-15,596
-77% -$2.1M ﹤0.01% 6520
2019
Q4
$2.83M Sell
20,298
-5,352
-21% -$703K ﹤0.01% 3790
2019
Q3
$3.03M Sell
25,650
-10,084
-28% -$1.25M ﹤0.01% 3474
2019
Q2
$4.63M Buy
35,734
+27,887
+355% +$3.44M ﹤0.01% 2819
2019
Q1
$1.01M Buy
7,847
+4,915
+168% +$621K ﹤0.01% 5030
2018
Q4
$326K Sell
2,932
-35,152
-92% -$4.25M ﹤0.01% 6837
2018
Q3
$5.19M Buy
38,084
+34,613
+997% +$4.5M ﹤0.01% 2655
2018
Q2
$416K Sell
3,471
-21,910
-86% -$2.58M ﹤0.01% 7172
2018
Q1
$3.06M Buy
25,381
+2,830
+13% +$355K ﹤0.01% 3227
2017
Q4
$2.81M Buy
22,551
+1,728
+8% +$221K ﹤0.01% 3342
2017
Q3
$2.79M Buy
20,823
+17,722
+571% +$2.31M ﹤0.01% 3339
2017
Q2
$390K Sell
3,101
-9,960
-76% -$1.2M ﹤0.01% 7099
2017
Q1
$1.55M Sell
13,061
-9,763
-43% -$1.14M ﹤0.01% 4192
2016
Q4
$2.46M Buy
22,824
+20,696
+973% +$2.25M ﹤0.01% 3637
2016
Q3
$245K Sell
2,128
-3,274
-61% -$373K ﹤0.01% 7254
2016
Q2
$553K Buy
+5,402
New +$576K ﹤0.01% 5953
2016
Q1
Sell
-7,334
Closed -$765K 8983
2015
Q4
$930K Sell
7,334
-25,118
-77% -$3.08M ﹤0.01% 5552
2015
Q3
$3.71M Buy
32,452
+20,779
+178% +$2.75M ﹤0.01% 3130
2015
Q2
$1.57M Sell
11,673
-18,487
-61% -$2.46M ﹤0.01% 5213
2015
Q1
$3.91M Sell
30,160
-14,338
-32% -$1.8M ﹤0.01% 3108
2014
Q4
$5.13M Buy
44,498
+18,840
+73% +$2.12M ﹤0.01% 2848
2014
Q3
$2.72M Sell
25,658
-9,636
-27% -$975K ﹤0.01% 4075
2014
Q2
$3.37M Sell
35,294
-30,213
-46% -$2.71M ﹤0.01% 3711
2014
Q1
$5.96M Sell
65,507
-58,276
-47% -$5.66M ﹤0.01% 2651
2013
Q4
$11M Buy
123,783
+79,801
+181% +$6.67M 0.01% 1954
2013
Q3
$3.64M Buy
43,982
+21,863
+99% +$1.72M ﹤0.01% 3180
2013
Q2
$1.51M Buy
+22,119
New +$1.54M ﹤0.01% 4344

Other funds holding BBH

Susquehanna International Group's BBH Position: Q1 2026 in Review

Susquehanna International Group increased its VanEck Biotech ETF (BBH) stake by 117% in Q1 2026, buying an estimated $268K and bringing the position to 2,579 shares worth $485K. The position accounts for ﹤0.01% of the portfolio, ranked #9756.

Susquehanna International Group first reported a position in BBH in Q2 2013 and has held it in 50 quarters since. The position peaked at $11M in Q4 2013. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

  • Susquehanna International Group held 2,579 shares of VanEck Biotech ETF worth $485K as of Q1 2026.
  • Susquehanna International Group bought 1,391 VanEck Biotech ETF shares in Q1 2026, an estimated $268K.
  • VanEck Biotech ETF made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9756 holding.
  • Susquehanna International Group first reported a position in VanEck Biotech ETF in Q2 2013 and has held it in 50 quarters since.
  • Susquehanna International Group's VanEck Biotech ETF position peaked at $11M in Q4 2013.
  • 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.